Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$32.28−0.16 (-0.49%)
Close on Nov 17, 2026Market cap $2.11BP/E –Yield –
Pharvaris net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2021 it was -€42.70M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -€42.70M | – |
| FY2020 | Dec 31, 2020 | -€25.99M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | -€21.90M | – |
| Q2 FY2022 | Jun 30, 2022 | -€12.71M | – |
| Q2 FY2021 | Jun 30, 2021 | -€15.20M | – |
See a number that looks wrong?